Insider trading

Period: 12 months Stock: XENE Type of trade: Sold × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

15 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

15 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

15 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

15 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
15 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
15 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

15 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
28 Aug 2026
KENNEY CHRISTOPHER JOHN Chief Medical Officer
Sold on a plan 2×
$425.83K 7,068 at 60.25
100.0%
Sold half or more
11 Aug 2026
GANNON STEVEN Director
Sold at will
$640.55K 10,000 at 64.06
84.2%
Sold half or more
5 Jun 2026
PATOU GARY Director
Sold on a plan
$70.25K 1,322 at 53.14
5.0%
Planned (10b5-1)
5 Jun 2026
Cannon Gillian Director
Sold on a plan
$63.24K 1,190 at 53.14
45.0%
Planned (10b5-1)
13 Mar 2026
MORTIMER IAN PRESIDENT & CEO
Sold on a plan
$403.58K 7,308 at 55.23
26.8%
Planned (10b5-1)
13 Mar 2026
KENNEY CHRISTOPHER JOHN Chief Medical Officer
Sold on a plan
$77.87K 1,410 at 55.23
16.6%
Planned (10b5-1)
13 Mar 2026
DiFabio Andrea Chief Legal Officer
Sold on a plan
$74.11K 1,342 at 55.23
15.5%
Planned (10b5-1)
10 Mar 2026
MORTIMER IAN PRESIDENT & CEO
Sold on a plan
$677.36K 11,269 at 60.11
43.3%
Planned (10b5-1)
10 Mar 2026
KENNEY CHRISTOPHER JOHN Chief Medical Officer
Sold on a plan
$166.56K 2,771 at 60.11
36.9%
Planned (10b5-1)
10 Mar 2026
DiFabio Andrea Chief Legal Officer
Sold on a plan
$156.70K 2,607 at 60.11
34.8%
Planned (10b5-1)
9 Mar 2026
MORTIMER IAN PRESIDENT & CEO
Sold on a plan 9×
$16.29M 270,000 at 60.33
97.8%
Sold half or more
2 Jan 2026
MORTIMER IAN PRESIDENT & CEO
Sold on a plan 2×
$1.78M 40,000 at 44.43
87.0%
Sold half or more
8 Dec 2025
MORTIMER IAN PRESIDENT & CEO
Sold on a plan 2×
$495.21K 10,830 at 45.73
64.3%
Sold half or more
5 Dec 2025
MORTIMER IAN PRESIDENT & CEO
Sold on a plan
$647.31K 14,375 at 45.03
46.1%
Planned (10b5-1)
28 Nov 2025
MORTIMER IAN PRESIDENT & CEO
Sold on a plan
$4.37K 97 at 45.01
0.3%
Planned (10b5-1)
Showing 1–15 of 15.